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It has previously been reported that rabbit antisera prepared with papain 
digests  of human malignant spleen  cell  membranes recognize antigens  ex- 
pressed by normal and neoplastic human B lymphocytes (1-3).  The antigens 
recognized by these antisera appear to be similar to, and may be identical with, 
the p23, 30 antigen identified by Humphreys and colleagues and by Schlossman 
and colleagues on normal B cells, 15-20% of null cells, and the majority of acute 
leukemia cells (4,  5).  A  surprising and unexplained observation was the fre- 
quent detection of similar antigens on acute and chronic myeloid (granulocytic) 
leukemia cells.  It was not clear why neoplastic myeloid cells should express an 
antigen found on mature B cells but not mature granulocytes. To answer this 
question, we examined the effects of similar antisera on normal human myeloid 
stem cells.  These cells, colony-forming unit-culture (CFU-C),  were assayed for 
their ability to form granulecyte and macrophage colonies in agar, in vitro (6, 7) 
in the presence or absence of antiserum and complement (C). It is now clear that 
the antigens recognized by such antisera also occur on normal myeloid pro- 
genitors. 
Materials and Methods 
Antisera.  As previously described,  antisera were raised in rabbits immunized with papain 
digests of cell membranes from the spleen of patients with a variety of hematologic neoplasms (1). 
Cells.  Heparinized  aspirates  of bone  marrow  were  obtained  from  appropriately  informed 
normal adult volunteers, and single cell suspensions were prepared as previously described (8). 
Heparinized peripheral blood of patients with chronic lymphocytic leukemia (CLL) was used to 
prepare  lymphocyte populations  of >98%  purity  for  absorption of antisera.  Permanent  tissue 
culture lines of B  cells  (pooled lines B44,  45,  and 47) and T  cells  (MOLT-4) were also used for 
absorption (1). 
Cytotoxicity Testing.  Normal bone marrow cells, 2 ×  106/ml, in 15% heat-inactivated fetal calf 
serum in McCoy's 5A medium were incubated with  1/10 volume of heated rabbit antiserum or 
heated normal rabbit serum at room temperature for 30 min. Normal rabbit serum, 1/10 volume, 
as a source of C was added for an additional 60 min. Cells were then plated in 0.3% agar above a 
feeder layer of 1 ×  10  ~ peripheral blood leukocytes for assay of CFU-C as previously described (8). 
After 10 days incubation the number of colonies with >40 cells were determined. Results were 
expressed as the percentage inhibition (mean _+ SD) of colony formation in experimental assays 
relative to appropriate controls. The concentration of fresh rabbit serum used to provide C had no 
inhibitory effect on human marrow colony formation. 
Results 
Antisera to  papain-digested  spleen  membranes inhibited  normal marrow 
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TABLE  I 
Cytotoxicity against Human CFU-C of Rabbit Antiserum Prepared against Spleen 
Cell Membranes 
Antiserum conoen-  Complement  Inhibition of  No. of experiments 
tration  addition  Absorption of antiserum  CFU-C (%  -+ SD) 
1:1,000  None  0  +- 0  9 
1:1,000  +  None  99 ±  2  9 
1:10,000  +  None  87 -+  4  9 
1:1,000  +  50  ×  10  s CLL cells  4  ±  2  3 
1:1,000  +  50  x  lip B-lymphoblsetoid cells  8  -+ 3  3 
1:1,000  +  50  x  106 T-lymphoblastoid cells  99 ±  2  3 
CFU-C  in  a  concentration-  and  C-dependent fashion  (Table  I).  Equivalent 
concentrations of fresh and heated serum from unimmunized rabbits had no 
inhibitory activity.  The  cytotoxic effect of antiserum and C  appeared to be 
directed against myeloid stem cells rather than against mature end cells, since 
no abortive colony formation was observed during the culture period and the 
serum was not cytotoxic against mature granulocytes as tested by the method of 
Terasaki and McClelland (9). 
The following experiments were performed to ascertain whether the antisera 
were detecting similar antigens on CFU-C and B lymphocytes. Antisera (300 ~1) 
were  absorbed  with  50  ×  10  e CLL  cells,  pooled lymphoblastoid B  cells,  or 
lymphoblastoid T cells (MOLT 4). Absorbed antisera were then tested for their 
inhibitory activity against normal marrow CFU-C. The results are shown in 
Table I and indicate identity of  the antigens present on CFU-C and on neoplastic 
(CLL) B cells and permanently growing lymphoblastoid B cells. A permanent 
cell line of T cells did not absorb inhibitory activity. To exclude the possibility 
that the B-lymphoblastoid cells were abrogating the inhibitory activity by the 
production of colony-stimulating activity  (CSA),  separate  studies were  per- 
formed with B-cell-conditioned media. No CSA was detected. 
Discussion 
Prior studies led to the conclusion that antisera prepared against papain- 
digested spleen cell membranes recognized antigens present on normal B lym- 
phocytes and  also  expressed by  the  majority  (>70%)  of acute  and  chronic 
lymphocytic and myelocytic leukemia cells and lymphoblastoid B-cell lines (1). 
The antisera have been shown to inhibit the mixed lymphocyte reaction. From 
these and F(ab')~ blocking studies (10), it appears that the B antigen represents 
the common region of the HLA-D molecule. Detailed studies suggested that the 
antisera  to  papainized cell  membranes reacted with a  larger  population of 
peripheral blood lymphocytes than those cells possessing surface-bound immu- 
noglobulin. Additionally, bone marrow preparations from 61 leukemic patients 
in remission and from normal subjects had low numbers of antigen-positive cells 
(0-4%).  The morphology of these positive cells was not determined. It is now 
clear that normal human myeloid stem cells also possess the antigen detected by 
these antisera. This observation probably explains the reaction of antisera with 
a larger population of cells than those expressing surface immunoglobulin and 
may explain the occurrence of antigen in association with neoplastic myeloid 
leukemia cells as well as neoplastic B cells (11). CLINE  AND  BILLING  BRIEF  DEFINITIVE  REPORT  1145 
Summary 
Antisera  prepared  against  papain-digested  spleen  cell  membranes  were 
known to be cytotoxic for normal and neoplastic human B lymphocytes and for a 
majority of  acute and chronic myeloid leukemic cells. It is now shown that these 
antisera are also cytotoxic for normal myeloid stem cells (CFU-C), thus provid- 
ing a probable explanation for their occurrence in myeloid neoplasia. 
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